| Authors: |
Abdel-Azim H; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Dave H; Center for Cancer and Blood Disorders, Children's National Hospital, George Washington School of Medicine, Washington, DC, USA., Jordan K; Department of Immunology and Microbiology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA., Rawlings-Rhea S; Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA., Luong A; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Wilson AL; Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA. Electronic address: ashley.wilson2@seattlechildrens.org. |
